Full text

Turn on search term navigation

© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The rapid development of the nuclear industry and mining has increased environmental radioactive contamination, posing potentially ecological risks and health threats to humans. Uranium compounds are known to exhibit selective nephrotoxicity, but their toxicological processes and mechanisms still remain poorly understood and controversial. In this study, the uranyl-induced toxicity in human renal tubular epithelial cells (HK-2) were explored using flow cytometry, DAPI staining, and comet assays. Our results demonstrate that uranium exposure primarily triggers apoptosis. Kyoto Encyclopedia of Genes and Genomes pathway enrichment and protein–protein interaction (PPI) analyses revealed significant associations with DNA damage. Moreover, aberrant expression of ABC transporters (e.g., ABCB7) and mitochondrial-related proteins confirms uranium-induced mitochondrial dysfunction. Gene Ontology functional annotation implicated extrinsic apoptotic signaling pathways in uranium-induced cell death. The downregulation of the UBL5 protein also pointed to endoplasmic reticulum stress-mediated apoptosis. In summary, uranium exposure can induce the apoptosis of HK-2 cells through intrinsic pathways by damaging DNA and mitochondria and disrupting protein synthesis, with secondary contributions from endoplasmic reticulum stress and extrinsic apoptotic signaling.

Details

Title
Toxicological Mechanisms of Uranium-Induced Apoptosis in HK-2 Cells: A Proteomics and Metabolomics Study
Author
Wang Zihuan 1 ; Huang, Yongxiang 2 ; Zhang, Yue 1 ; Wu Xuejuan 1 ; Yang, Yuanyuan 1 ; Song Jiayu 3 ; Guo Kunling 4 ; Wang, Mingyuan 2 ; Chen, Junjie 3 ; Shirong, Qiang 1   VIAFID ORCID Logo 

 Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Institute of Physiology, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, China; [email protected] (Z.W.); [email protected] (Y.Z.); [email protected] (X.W.); [email protected] (Y.Y.) 
 The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, China; [email protected] (Y.H.); [email protected] (M.W.) 
 Northwest Institute of Eco-Environment and Resources, Chinese Academy of Sciences, Lanzhou 730000, China; [email protected] (J.S.); [email protected] (J.C.) 
 School of Public Health, Shanghai Jiao Tong University, Shanghai 200025, China; [email protected] 
First page
699
Publication year
2025
Publication date
2025
Publisher
MDPI AG
e-ISSN
23056304
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3244066479
Copyright
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.